BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16448891)

  • 1. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy.
    Cordero A; Laclaustra M; León M; Grima A; Casasnovas JA; Luengo E; del Rio A; Ferreira I; Alegria E
    Am J Hypertens; 2006 Feb; 19(2):189-96; discussion 197-8. PubMed ID: 16448891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and new category 'pre-hypertension' in a Japanese population.
    Kanauchi M; Kanauchi K; Hashimoto T; Saito Y
    Curr Med Res Opin; 2004 Sep; 20(9):1365-70. PubMed ID: 15383184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum lipid values in subjects with and without the metabolic syndrome.
    Cordero A; Laclaustra M; León M; Casasnovas JA; Grima A; Luengo E; Ordoñez B; Bergua C; Bes M; Pascual I; Alegría E;
    Am J Cardiol; 2008 Aug; 102(4):424-8. PubMed ID: 18678299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure--the TRACA study.
    Cordero Fort A; Gavira JJ; Alegría-Barrero E; Castaño S; Martín A; Ubilla M; Mastrobuoni S; Alegría Ezquerra E; Herreros J; Rábago G
    J Heart Lung Transplant; 2006 Oct; 25(10):1192-8. PubMed ID: 17045931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage.
    Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G
    Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
    Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
    Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in obesity related cardiovascular risk factors in Spain.
    Cordero A; León M; Andrés E; Ordoñez B; Laclaustra M; Grima A; Pascual I; Luengo E; Civeira F; Pocoví M; Alegría E; Casasnovas JA;
    Prev Med; 2009 Feb; 48(2):134-9. PubMed ID: 19038283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between mild renal dysfunction and insulin resistance or metabolic syndrome in a random nondiabetic population sample.
    Onat A; Hergenç G; Uyarel H; Ozhan H; Esen AM; Karabulut A; Albayrak S; Can G; Keleş I
    Kidney Blood Press Res; 2007; 30(2):88-96. PubMed ID: 17347575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study.
    Solbu MD; Jenssen TG; Eriksen BO; Toft I
    Metabolism; 2009 Mar; 58(3):408-15. PubMed ID: 19217459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
    Sierra-Johnson J; Somers VK; Kuniyoshi FH; Garza CA; Isley WL; Gami AS; Lopez-Jimenez F
    Am J Cardiol; 2006 Nov; 98(10):1369-73. PubMed ID: 17134631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertensive women with the metabolic syndrome are at risk of renal insufficiency more than men in general population.
    Korhonen P; Aarnio P; Vesalainen R; Saaresranta T; Kautiainen H; Järvenpää S; Kantola I
    J Hum Hypertens; 2009 Feb; 23(2):97-104. PubMed ID: 18784736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects.
    Kim BJ; Kim TY; Koh JM; Kim HK; Park JY; Lee KU; Shong YK; Kim WB
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):152-60. PubMed ID: 18494864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.
    Gatti A; Morini E; De Cosmo S; Maiani F; Mandosi E; Fallarino M; Morano S; Trischitta V
    Obesity (Silver Spring); 2008 Apr; 16(4):899-901. PubMed ID: 18239564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
    Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
    Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.